NCT03396393View on ClinicalTrials.gov

Exploratory Study of DHA in Systemic Lupus Erythematosus Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Systemic Lupus Erythematosus
Interventions
DRUG

Dihydroartemisinin tablet

DHA tablet

DRUG

Placebo tablet

Placebo tablet

Sponsors
All Listed Sponsors
lead

Kunming Pharmaceuticals, Inc.

INDUSTRY